Market research
IXI.LSE IXICO plc
LSE GBP Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 17M
- P/E ratio
- Not available
- Analyst target
- 26
- Dividend yield
- Not available
- Beta
- 0.11
Profile
Company facts
- Exchange
- LSE
- Currency
- GBP
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- GB00BFXR4C20
- Market cap
- 17M
- P/E ratio
- Not available
- Analyst target
- 26
- Dividend yield
- Not available
- Beta
- 0.11
About
About IXICO plc
IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collection, analysis, management, and reporting on gathered clinical study data; neurological diseases data collection and analysis; and sales and marketing services. It also provides imaging contract research organization solutions, including imaging biomarkers, such as radiological reads, volumetric MRI, PET and SPECT, and advanced MRI; trial management; data analytics; post marketing surveillance and clinical diagnostics; and consultancy services. In addition, the company offers IXICO platform, an AI-enabled technology platform for neuroimaging data management and analysis. Its services are used for various therapeutic areas comprising Alzheimer's, Huntington's, Multiple Sclerosis, and Parkinson's diseases, as well as other rare neurological diseases, other Demyelinating disorders, and other Parkinsonian disorders. It has collaboration with Medidata to create neuroimaging clinical trials platform. The company is based in London, the United Kingdom.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the IXI.LSE discussion.
5 years, 5 months ago
IXICO plc is currently in a long term downtrend where the price is trading 23.1% below its 200 day moving average.
From a valuation standpoint, the stock is 99.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.4.
IXICO plc's total revenue sank by 0.0% to $2M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $108K since the same quarter in the previous year.
Finally, its free cash flow grew by 6017.9% to $856K since the same quarter in the previous year.
Based on the above factors, IXICO plc gets an overall score of 2/5.